High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer

Metastatic colorectal cancer is a leading cause of cancer death. However, current therapy options are limited to chemotherapy, with the addition of anti-EGFR antibodies for patients with RAS wild-type tumours. Novel drug targets, or drug combinations that induce a synergistic response, would be of g...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Sci Data
Prif Awduron: Williams, Steven P., Barthorpe, Andrew S., Lightfoot, Howard, Garnett, Mathew J., McDermott, Ultan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2017
Pynciau:
Data Descriptor
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5625556/
https://ncbi.nlm.nih.gov/pubmed/28972570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sdata.2017.139
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg